Technical Analysis for RTTR - Ritter Pharmaceuticals, Inc.
|Grade||Last Price||% Change||Price Change|
RTTR closed down 1.45 percent on Friday, January 18, 2019, on 1.33 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
|Weak or Absent||Down||Down||Down|
|See historical RTTR trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||20 DMA Resistance||Bearish||0.00%|
|Jan 18||NR7||Range Contraction||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Down 3 Days in a Row||Weakness||0.00%|
|Jan 18||Down 4 Days in a Row||Weakness||0.00%|
|Jan 17||Fell Below 20 DMA||Bearish||-1.45%|
|Jan 17||Inside Day||Range Contraction||-1.45%|
|Jan 17||Wide Bands||Range Expansion||-1.45%|
|Jan 17||Down 3 Days in a Row||Weakness||-1.45%|
|Jan 16||20 DMA Support||Bullish||-6.85%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal, and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. RP-G28 has been studied in a Phase 2a clinical trial. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more RTTR news...
|52 Week High||4.0|
|52 Week Low||0.47|
|200-Day Moving Average||1.9754|
|50-Day Moving Average||0.7898|
|20-Day Moving Average||0.7118|
|10-Day Moving Average||0.7784|
|Average True Range||0.1088|
|Chandelier Exit (Long, 3 ATRs )||0.6236|
|Chandelier Exit (Short, 3 ATRs )||0.7964|
|Upper Bollinger Band||0.9437|
|Lower Bollinger Band||0.4799|
|Percent B (%b)||0.43|
|MACD Signal Line||-0.0235|
|Market Cap||10.04 Million|
|Num Shares||14.8 Million|
|Price-to-Earnings (P/E) Ratio||-0.51|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||0.77|
|Resistance 3 (R3)||0.78||0.75||0.76|
|Resistance 2 (R2)||0.75||0.73||0.75||0.75|
|Resistance 1 (R1)||0.72||0.72||0.71||0.71||0.74|
|Support 1 (S1)||0.66||0.67||0.65||0.65||0.62|
|Support 2 (S2)||0.63||0.66||0.63||0.61|
|Support 3 (S3)||0.60||0.63||0.61|
|Support 4 (S4)||0.59|